Navigation Links
Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
Date:1/8/2008

partner product candidates may not issue, patents that have issued may not be enforceable or sufficient to protect against competitive products, or intellectual property licenses from third parties may be required in the future, (vi) the outcome of any existing or future intellectual property or other litigation related to the company's proprietary product candidates, and (vii) potential competition from existing approved products (branded or generic) or product candidates under development by other companies could negatively impact the commercial potential of the company's product candidates due to such competitive factors as efficacy and safety profiles, pricing, and reimbursement by third party payers. Other important risks and uncertainties are detailed in the company's reports and other filings with the Securities and Exchange Commission (SEC), including its most recent Quarterly Report on Form 10-Q filed with the SEC on November 9, 2007. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise. No information regarding or presented at the company's R&D day either posted on the company's website or presented orally or visually through the Webcast is intended to be incorporated by reference in this press release.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
2. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
3. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
4. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
5. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
6. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
7. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)...  Boston Scientific has released the primary endpoint ... Failure (NECTAR-HF) clinical trial, the first and only ... (VNS) for the treatment of heart failure patients.  ... Cardiology and Director of the Clinical Investigation Center ... de la Recherche Medicale presented the results at ...
(Date:8/30/2014)... Mass. , Aug. 30, 2014   Royal ... of Affiniti, a new ultrasound system designed ... the demands of increasing patient volumes and cost pressures. ... Congress 2014 in Barcelona ... departments facing more patients with fewer resources deliver high ...
(Date:8/29/2014)... /PRNewswire-iReach/ -- Market Research Report on Global and ... professional and in-depth market survey on Global ... report firstly reviews the basic information of X-Ray ... technology. The report then explores global and China,s ... product specification, capacity, Production value, and market share ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
(Date:8/31/2014)... (PRWEB) August 31, 2014 Green ... harmful disc brake dust at the source while ... Problem: Millions of vehicles globally emit brake dust/debris ... in the friction materials (disc brake pads) are ... nations’ water systems. For example, copper impairs and ...
(Date:8/31/2014)... Priya Khan, Director of Research & Development at ... weight-loss supplements saying, “Consumers are understandably frustrated with ... propagated by unscrupulous companies about weight-loss products.” Even ... the subject. , NutriGold’s mission is to educate ... and to provide them with guidelines for choosing ...
(Date:8/31/2014)... August 31, 2014 To make it ... brand they can trust, NutriGold is shipping complimentary samples ... form has been set up to make taking advantage ... , According to Priya Khan, Director of Research and ... purchase one of our products, they are entrusting us ...
(Date:8/31/2014)... 2014 “Prohibition is our history,” ... our future: the present ~ that’s political.” , ... , new on the Bryan William Brickner Blog, ... system (CS) modulation and homeostasis - including one ... use. The Publius CS update includes: heteromerization ...
(Date:8/31/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ), Bluehost and GoDaddy are the best hosting ... Top10BestSEOHosting.com says, “These companies have outperformed other competitors ... so that we call them the Best VPS ... get the best web hosting to enjoy the ...
Breaking Medicine News(10 mins):Health News:CBPModular Technology with Global Patent Coverage Solves Vehicle Wheel Brake Dust Problem 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Homeostasis: Publius’ Alcohol Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:Top10BestSEOHosting.com Announces The Best Hosting Suppliers In 2014: iPage, Bluehost and GoDaddy 2
... events , WEDNESDAY, May 5 (HealthDay News) -- A ... significantly cuts down on hospital drug errors, researchers from ... "We had the opportunity to design and implement a ... the hospital gets the right medication at the right ...
... those mental illnesses are still common, especially among women, survey ... report finds that older people have lower rates of mental ... the conditions remain common, especially in women. , Researchers led ... San Francisco analyzed a survey of 2,575 people aged 55 ...
... it may not help older men and women with sexual problems ... partner report greater happiness and those who talked with friends ... Journal of Gerontology: Social Sciences , shows that the way ... later years varies greatly and that there is not one solution ...
... ... Healthy CHOICES Act, and just days after the release of America’s first-ever ... and leaders from the fitness industry are gathering on Capitol Hill as ... will meet with Members of Congress to share their vision for a ...
... ... with online resources dedicated to the technical requirements associated with large format touch screens. ... particular makes this need an immediate one. See how they answered the call... ... (PRWEB) May 5, ...
... Research Institute (CRI) is participating in an international study ... and chronic lymphocytic leukemia. "This study is important ... to treat patients with leukemia or lymphoma," said Arthur ... Research Institute, and principal investigator for the Temple portion ...
Cached Medicine News:Health News:Bar Codes Cut Down on Hospital Medication Errors 2Health News:Bar Codes Cut Down on Hospital Medication Errors 3Health News:Friendship and confiding in spouse eases stress over sexual issues in older men 2Health News:Friendship and confiding in spouse eases stress over sexual issues in older men 3Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 2Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 3Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 4Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 5Health News:Horizon Display Demonstrates their Dedication to After-Sales Support with Enhanced Online Resources 2Health News:Horizon Display Demonstrates their Dedication to After-Sales Support with Enhanced Online Resources 3Health News:Scott & White Healthcare clinical trials target lymphoma, leukemia 2
A One Piece Support Garment - any length or size...
Body Suit w/Bra torso...
Male Compression Vest Binder...
Ideal for breast compression with adjustable hook and eye closure....
Medicine Products: